|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/28/21 Dna Brands Inc. 1-A/A 3:39K Empire Stock Transf… Inc |
Document/Exhibit Description Pages Size
1: 1-A/A Pre-Qualification Amendment to Offering Statement HTML 3K
-- primary_doc.xml
2: PART II AND III Part Ii HTML 16K
3: EX1A-12 OPN CNSL Legal Opinion HTML 9K
| PART II |
Registration No. 024-11471
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-A/A
Amendment #6
REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933
DNA BRANDS, INC.
(Exact name of issuer as specified in its charter)
Colorado
(State or other jurisdiction of incorporation or organization)
275 E Commercial Blvd #208
Lauderdale by the Sea, FL 33308
(561) 654-5722
(Address, including zip code, and telephone number,
including area code, of issuer’s principal executive office)
URS Agents LLC
36 South 18th Avenue
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
| 7371 |
| 26-0394476 |
| (Primary Standard Industrial Classification Code Number) |
| (IRS Employer Identification Number) |
This Offering Circular shall only be qualified upon order of the Commission, unless a subsequent amendment is filed indicating the intention to become qualified by operation of the terms of Regulation A.
EXPLANATORY NOTE
PRELIMINARY OFFERING CIRCULAR SUBJECT TO COMPLETION,
DATED APRIL 28, 2021
An offering statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission on March 3, 2012, including restated amendments made there to Form 1-A/A on March 19, 2021 (“Amendment No. 1”), March 30, 2021 (“Amendment No. 2), April 8, 2021 (“Amendment No. 3”), April 13, 2021 (“Amendment No. 4”) and April 26, 2021 (“Amendment No. 5”). This ‘exhibits only’ amendment is solely filed to include exhibit 12.1, the Legal Opinion of Jeff Turner, P.A..
These securities may not be sold nor may offers to buy be accepted before the offering statement filed with the Commission is qualified. The offering statement shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sales of these securities in any state in which such offer, solicitation or sale would be unlawful before registration or qualification under the laws of any such state. We may elect to satisfy our obligation to deliver a Final Offering Circular by sending you a notice within two business days after the completion of our sale to you that contains the URL where the Offering Circular was filed may be obtained.
2
PART III - EXHIBITS
| Exhibit Number | Exhibit Description |
| Subscription Agreement | |
| Employment Agreement between DNA Brands, Inc. and Adrian McKenzie/ PBDC LLC | |
| Software Acquisition Agreement between DNA Brands, Inc. and Santo Blockchain Labs Corp. | |
| 11.1 |
Consent of Jeff Turner, P.A. (included in the Opinion) |
| Opinion of Jeff Turner, P.A.* |
PIII-1
SIGNATURE
Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on behalf by the undersigned, thereunto duly authorized, in Fort Lauderdale, State of Florida, on April 28, 2021.
DNA BRANDS, INC.
This Offering Statement has been signed by the following persons in the capacities and on the dates indicated.
By: /s/ Adrian McKenzie
Name: Adrian McKenzie
Title: Chief Executive Officer, Director and Principal Financial Officer
Date: April 28, 2021
By: /s/ Adrian McKenzie
Name: Adrian McKenzie
Title: Chief Financial Officer (Principal Financial Officer)
Date: April 28, 2021
SIGNATURES OF DIRECTORS:
By: /s/ Adrian McKenzie
Name: Adrian McKenzie
Title: Chief Executive Officer, Director
Date: April 28, 2021
PIII-2
| This ‘1-A/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/28/21 | 1-A-W | ||
| 4/26/21 | 1-A/A | |||
| 4/13/21 | 1-A/A | |||
| 4/8/21 | 1-A/A, UPLOAD | |||
| 3/30/21 | 1-A/A | |||
| 3/19/21 | 1-A/A | |||
| 3/3/12 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/27/21 Dna Brands Inc. 1-A POS 2:905K Empire Stock Transf… Inc |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/13/21 Dna Brands Inc. 1-A/A 3:86K Empire Stock Transf… Inc 3/03/21 Dna Brands Inc. 1-A 7:1.4M Empire Stock Transf… Inc |